CCL20, MMP14, and PCDH7 were upregulated in LUAD tumor tissues and linked to poor clinical outcomes, while BTG2, CD69, GPC3, IL7R, and NMUR1 are the opposite. This evidence concerns the gene CD69 and neoplasm.